Advertisements

Novaclox-LB

Quick links to important sections

Novaclox-LB

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Novaclox-LB

This section defines the composition, classification, and general purpose of Novaclox-LB, strictly avoiding details on dosage, specific treatments, usage instructions, or warnings.

Property Description
Active Ingredients Amoxicillin, Dicloxacillin (or Cloxacillin), and Lactobacillus Sporogenes
Form Capsule, Dry Syrup, Suspension
Pharmacological Class beta-Lactam Antibiotic and Probiotic Supplement
Common Use Management of bacterial infections and maintenance of gut flora
Origin Semi-synthetic (Antibiotics) and Biologic (Probiotic)

What Type of Medicine is Novaclox-LB?

Novaclox-LB is classified as a dual-action, prescription combination medicine intended for oral use, commonly marketed by Cipla Ltd. It belongs to the beta-lactam antibiotic class due to its antibacterial agents, strategically combined with a probiotic supplement. This unique composition is designed for providing systemic infection treatment alongside targeted intestinal support. The medicine is available in both a capsule for adult use and a reconstitutable dry syrup or suspension for patients requiring a liquid format.


Active Composition and Origin: The Dual Component System

The formula’s efficacy relies on its multi-component nature, utilizing two semi-synthetic penicillins and a single biologic agent. The primary antibacterial components are Amoxicillin, an aminopenicillin, and Dicloxacillin (or Cloxacillin), which is classified as a penicillinase-resistant penicillin. This specific antibiotic pairing is utilized for its broad activity. The unique differentiating feature is the inclusion of Lactobacillus Sporogenes (a biologic agent), which transforms the product into a system designed to preserve the healthy microbiota of the gastrointestinal tract.


The General Purpose of the Antibiotic-Probiotic Combination

The overall purpose of Novaclox-LB is to achieve clearance of bacterial pathogens while proactively mitigating digestive distress. The bactericidal action of the penicillins targets the elimination of bacteria, which is the primary therapeutic goal. The concurrent administration of the probiotic component serves the fundamental purpose of maintaining intestinal balance. This integrated approach is intended to provide comprehensive anti-infective treatment and support for gut health.

Regulatory References

  1. NIH Review on Probiotics and Antibiotics
Advertisements

What side effects are possible with Novaclox-LB?

Possible side effects and safety information

The official regulatory safety profile for this combination medicine is primarily based on the documented adverse reactions of its beta-lactam antibiotic components (Amoxicillin and Cloxacillin/Dicloxacillin). Side effects are formally classified by frequency and grouped according to the specific body systems they may affect.

Adverse Reaction Scope

Adverse reactions are classified as Common when they include gastrointestinal disturbances such as Nausea, Vomiting, and Diarrhoea, as well as certain types of skin Rash. Effects categorized as Uncommon, Rare, or Very Rare in official documents include blood and lymphatic system disorders, hepatic dysfunction, and nervous system disturbances.

System-Organ Class Examples of Documented Effects
Gastrointestinal Disorders Diarrhoea, Pseudomembranous Colitis
Skin and Subcutaneous Tissue Disorders Urticaria, Severe Cutaneous Adverse Reactions
Hepatobiliary Disorders Cholestatic Jaundice, Hepatitis

Serious Adverse Reactions and Safety Constraints

The label explicitly details Serious Adverse Reactions, which, though rare, are considered clinically significant. These include immediate, severe Anaphylaxis and serious skin reactions such as Stevens-Johnson Syndrome (SJS). Furthermore, Clostridium difficile-Associated Diarrhoea (CDAD) is noted as a potential risk.

Specific safety considerations are defined for certain populations. Caution is officially documented for use in patients with pre-existing Renal or Hepatic Impairment, as these conditions may alter the medicine's safety profile. The use of penicillin-class antibiotics is Contraindicated in individuals with a known history of hypersensitivity to any penicillin.

Advertisements

Overdose and Emergency Response

Novaclox-LB contains two beta-lactam antibiotics, Amoxicillin and Cloxacillin, alongside Lactobacillus spores. Taking more than the prescribed dose may increase the risk and severity of adverse effects associated with the antibiotic components.

Potential Overdose Symptoms

The most common symptoms of an overdose often involve the gastrointestinal system, though more serious reactions are possible, especially with very high doses or in patients with impaired kidney function. Overdose symptoms may include:

  • Gastrointestinal Distress: Severe or persistent nausea, vomiting, and diarrhea. Increased diarrhea may also be an indication of antibiotic-associated colitis.
  • Renal Effects: Kidney damage can occur with very high doses, potentially manifesting as changes in the amount or appearance of urine (e.g., cloudy urine).
  • Neurological Effects (Rare but Serious): High concentrations of beta-lactams in the central nervous system, particularly in individuals with pre-existing kidney problems, can rarely lead to symptoms such as agitation, confusion, or convulsions.

When to Seek Help

If you suspect an overdose of Novaclox-LB, it is crucial to seek immediate medical attention. Overdose management is primarily supportive and focused on maintaining vital functions and managing specific symptoms. The Lactobacillus component is generally considered safe and is not a factor in antibiotic toxicity.

Immediately contact emergency medical services or go to the nearest emergency room if:

  • You or someone else has taken a dose significantly higher than prescribed.
  • Symptoms of a severe allergic reaction occur, such as swelling of the face, throat, or tongue, difficulty breathing, or a widespread, severe rash.
  • Any signs of severe central nervous system effects, such as seizures or severe confusion, are present.

Contact your doctor or a poison control center for medical advice if you experience severe and persistent gastrointestinal distress or any concerning changes in urine output after taking this medication.

Advertisements

Therapeutic Uses of Novaclox-LB

What Novaclox-LB Treats: Main Uses and Benefits

Novaclox-LB is a fixed-dose combination (FDC) medication relevant in contexts marked by increased discomfort or tension related to bacterial infections. It is applied across therapeutic domains where additional symptomatic support is needed.

The combination is commonly used across conditions presenting with systemic or localized discomfort, such as those involving respiratory, skin and soft tissue, or ear, nose, and throat systems. It is applied when groups of symptoms appear suddenly or fluctuate. This formulation is utilized in clinical scenarios where multiple pathways of infection and related symptoms require simultaneous management.

The formulation generally helps support general well-being during symptomatic phases, particularly during periods where symptoms that interfere with daily functioning become more noticeable. This supports general well-being that assists with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms.


Quick Facts: Support for Symptom Management

  • Condition Categories: Commonly used across conditions involving episodic or fluctuating manifestations.
  • Symptom Focus: Helps address symptom clusters that may become intense or disruptive.
  • Patient Benefit: Offers symptomatic relief that may help patients cope more steadily with symptom fluctuations.

Regulatory References

  1. CDSCO (Central Drugs Standard Control Organisation) of India
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Novaclox-LB — Official Regulatory Information

This section defines the official population eligibility and exclusion rules for Novaclox-LB (Amoxicillin/Cloxacillin or Dicloxacillin and Lactobacillus Sporogenes) as mandated by governmental regulatory bodies.


Eligibility Scope

Classification Eligibility Rule Regulatory Status
Contraindicated Patients with known hypersensitivity to penicillins or a history of severe allergic reactions to other beta-lactam agents (e.g., cephalosporins). Absolute Prohibition
Patients with a history of cholestatic jaundice or liver dysfunction associated with previous penicillin use. Absolute Prohibition
Not Recommended Individuals with Infectious Mononucleosis (Glandular Fever). Strong Exclusion
Patients with severe kidney disease (severe renal impairment). Strong Exclusion
Conditional Use Pregnancy and Lactation status. Caution Required
Patients with hepatic impairment (liver disease). Caution Required
Patients with non-severe impaired renal function. Caution Required

Age-Related and Specific Constraints

  • Adults and Older Adults are generally considered eligible populations. Caution is applied to older adults if accompanying hepatic or renal impairment is present.
  • Pediatric Use is established; however, liquid forms are typically used for younger children, and capsule use is often restricted to adolescents over 12 years of age or ge 40 kg.

The eligibility status for Novaclox-LB is primarily determined by absolute contraindications related to prior allergic reactions to its antibiotic components and pre-existing conditions that affect drug clearance, such as severe renal or hepatic impairment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details official regulatory information regarding interactions between Novaclox-LB and other substances, primarily driven by its penicillin components (Amoxicillin and Cloxacillin/Dicloxacillin).


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Class Official Interaction Statement Constraint Classification
Probenecid (Uricosuric) Decreases the renal tubular secretion of the penicillin components, resulting in increased and prolonged blood levels of the antibiotics. Exposure Increase
Methotrexate (Antineoplastic) Penicillins may increase the serum concentration of Methotrexate due to impaired renal clearance, increasing the risk of toxicity. Exposure Increase / Toxicity Risk
Oral Anticoagulants (e.g., Warfarin) May increase the prolongation of prothrombin time (INR), thereby increasing the risk of bleeding. This effect relates to alteration of gut flora. Pharmacodynamic Change
Oral Contraceptives (Hormonal) The antibiotic components may reduce the efficacy of combined oral contraceptives. Efficacy Reduction
Allopurinol Concurrent use with Amoxicillin is documented to increase the risk of developing a skin rash. Pharmacodynamic Risk
Live Bacterial Vaccines (e.g., Typhoid) Systemic antibacterials may diminish the therapeutic effect of the live vaccine. Contraindication/Timing

Administration-Related Interaction Constraints

The absorption of the Cloxacillin or Dicloxacillin component is officially documented to be reduced by food, necessitating a timing requirement for administration apart from meals. The label also notes that high concentrations of the penicillin component may cause false-positive reactions in urinary glucose tests that use cupric sulfate solutions. This information is based strictly on regulatory documents for the active components.

Advertisements

Mechanism of Action

How Novaclox-LB Works

Bactericidal Disruption of Cell Wall Synthesis

The antibiotic components, amoxicillin and cloxacillin, are beta-lactam agents that act by irreversibly binding to Penicillin-Binding Proteins (PBPs). These transpeptidase enzymes are essential for the final cross-linking of the bacterial cell wall component, peptidoglycan. This binding process inhibits the formation of a rigid, structurally sound bacterial wall. Cloxacillin possesses a structural feature that circumvent the hydrolytic action of certain bacterial enzymes, such as penicillinase. The resulting disruption and weakening of the cell wall lead to osmotic instability and subsequent cell lysis of actively multiplying bacteria, which is the mechanism for the death and clearance of susceptible bacterial populations.

Ecological Modulation of Gut Microbiota

The probiotic component, typically a species of Lactobacillus, counteracts antibiotic-induced dysbiosis. It establishes a temporary presence in the intestinal lumen, contributing to the temporary restoration of the bacterial population profile. The Lactobacilli compete with other microbial species for adhesion sites and nutrients, and produce metabolites like lactic acid that modulate the microenvironmental pH. This mechanism influences the epithelial cell signaling and local metabolite production in a manner correlated with modulation of water and electrolyte transport processes, contributing to the regulation of the gut microenvironment.

Advertisements

Dosage and Administration Information

How to Use Novaclox-LB: Official Administration Guidelines

This section outlines the non-clinical, label-based instructions for the proper use of Novaclox-LB, as specified in regulatory and prescribing information, without reference to efficacy or safety.


Administration Scope

Property Description
Route of Administration Oral administration only (via capsule or a liquid suspension/dry syrup).
Dosing Schedule Standard adult dosing typically involves one capsule per dose, taken in a divided regimen, often two to four times daily (e.g., every 6 to 12 hours), as per the prescribing instructions for the component antibiotics.
Timing in Relation to Meals While component antibiotics (Dicloxacillin) are generally best taken on an empty stomach for maximum absorption, the combination product is commonly advised to be taken with or without food but at a fixed time each day to maintain consistent blood levels.
Preparation Requirements Capsules must be swallowed whole with water. They should not be crushed, broken, or chewed. The Dry Syrup requires proper reconstitution with water before being administered orally.

Procedural and Population Rules

Property Description
Course Duration The full prescribed course of treatment (typically 7 to 21 days) must be completed to ensure full delivery of the regimen, even if symptoms begin to resolve early.
Population Adjustments Dose intervals must be increased or adjusted for patients with severe renal impairment due to the component antibiotics' renal excretion profile. Caution is advised in hepatic impairment.
Missed Dose Rule If a dose is missed, it should be taken as soon as remembered. If it is close to the next scheduled dose, the missed dose should be skipped, and the regular schedule continued. Do not take a double dose to compensate.

Connection to the Overall Use Protocol

Official instructions standardize Novaclox-LB use as an oral, fixed-unit regimen taken multiple times per day. The protocol is strictly time-bound, requiring both fixed daily timing and full course completion to ensure proper delivery of the combined ingredients. This framework also mandates specific dose consideration for populations with renal impairment.

Advertisements

Recent Clinical Evidence

Novaclox-LB is a combination medication containing two beta-lactam antibiotics, Amoxicillin and Dicloxacillin, alongside Lactobacillus (a probiotic). Clinical evidence for this combination focuses primarily on the efficacy of the antibiotic components in treating bacterial infections and the role of the probiotic component in mitigating common antibiotic-related side effects.

Efficacy in Bacterial Infections

Amoxicillin and Dicloxacillin are broad-spectrum antibiotics, with Amoxicillin targeting a wide range of bacteria and Dicloxacillin specifically targeting certain penicillinase-producing bacteria (bacteria resistant to standard penicillin). Clinical trials have demonstrated that the combined use of these agents is associated with clinical success in treating various bacterial infections, including those of the respiratory tract (such as bronchitis and pneumonia), skin, urinary tract, and ear. The selection of this combination is typically guided by the suspected or confirmed type of bacterial pathogen.

Role of the Probiotic Component

Antibiotic use can disrupt the natural balance of beneficial bacteria in the gut, a condition known as dysbiosis, which frequently results in antibiotic-associated diarrhea (AAD). Clinical research suggests that the inclusion of Lactobacillus in the formulation helps to support the restoration of the intestinal microflora. Specifically, studies indicate that supplementation with Lactobacillus strains may reduce the incidence and severity of AAD in some patients undergoing antibiotic therapy. This supportive role is considered a benefit for maintaining gastrointestinal health during the course of the anti-infective treatment.

Key Safety Profile Observations

In clinical settings, the overall safety profile of Novaclox-LB is generally consistent with that of its component antibiotics. Adverse events reported are typically gastrointestinal in nature, such as nausea, vomiting, and diarrhea (despite the probiotic inclusion). Hypersensitivity reactions (allergic reactions) associated with penicillin-class antibiotics, though uncommon, remain a potential risk, reinforcing the need for careful patient screening.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Novaclox-LB (FAQ)


Q: How quickly can a person expect to start feeling better after beginning Novaclox-LB?

A: Official information indicates that the medicine's onset of action—meaning when the ingredients begin working—is typically seen within an hour of administration. However, feeling clinical improvement, such as a reduction in symptoms, can take longer. Official guidance emphasizes the importance of completing the full prescribed course.

Q: Is it normal to experience nausea or stomach upset while taking this medicine?

A: Yes, regulatory documents classify nausea and gastrointestinal upset as common side effects of this medicine. The product label states that taking the medicine with food may help to minimize stomach upset. If stomach issues are severe or persistent, this information should be relayed to a healthcare professional.

Q: Does Novaclox-LB cause diarrhea, and if so, how does the Lactobacillus component help?

A: The antibiotic components of the medicine can cause diarrhea as a common side effect. The inclusion of Lactobacillus is intended to support the balance of intestinal flora, a measure correlated with regulating the gut microenvironment. This supportive role may help counteract antibiotic-associated dysbiosis.

Q: What are the restrictions on using Novaclox-LB for someone with pre-existing kidney conditions?

A: Caution is formally advised for patients with existing kidney diseases, as the antibiotic components are cleared through the kidneys. Regulatory guidelines state that dose adjustments, specifically increasing the interval between doses, are necessary for patients with severe kidney impairment. The medicine is generally strongly excluded for use in patients with severe kidney disease.

Q: Is Novaclox-LB safe to use during pregnancy, according to official classifications?

A: Official prescribing information notes that caution is required for use during pregnancy. While the Amoxicillin component is often categorized as Pregnancy Category B, use of the combined product during pregnancy requires a careful assessment of potential benefit versus risk, as determined by a healthcare provider.

Q: What is the official guidance on taking Novaclox-LB while breastfeeding?

A: Official guidance indicates that use while breastfeeding requires caution. Information suggests the drug may not pass into breast milk in significant amounts, but this must be assessed on a case-by-case basis by a healthcare professional.

Q: What is the risk of developing a secondary fungal infection, like oral thrush or vaginal yeast infection?

A: The use of antibiotics can sometimes lead to a secondary fungal infection, such as oral thrush or vaginal candidiasis (yeast infection). These events are listed in regulatory documents as less common, but potential, side effects of the antibiotic components.

Q: What is the difference between Novaclox-LB and a simple amoxicillin drug?

A: Novaclox-LB is a combination medicine containing two active antibiotics: Amoxicillin and Dicloxacillin (or Cloxacillin), plus a Lactobacillus probiotic. In contrast, a simple Amoxicillin drug contains only the single antibiotic agent. The combination is designed to provide broader antibacterial coverage and gut support.

Q: Is Novaclox-LB considered a broad-spectrum antibiotic?

A: Yes, official summaries characterize the combination of Amoxicillin and Dicloxacillin as providing broad-spectrum antibacterial activity. This means the medicine is effective against a wide range of bacterial types.

Q: Is the Lactobacillus in Novaclox-LB the same as a probiotic supplement?

A: Yes, the Lactobacillus Sporogenes component in the medicine is a biologic agent and is formally classified as a probiotic supplement. Its core purpose is to support the healthy balance of intestinal flora during antibiotic treatment.

Q: Can Novaclox-LB cause dizziness or lightheadedness?

A: Official prescribing information includes dizziness as a potential side effect, although it is typically categorized as uncommon. If dizziness or lightheadedness occurs, care should be taken when standing or moving.

Q: Does Novaclox-LB affect the color of your teeth?

A: While not a common effect, some penicillins have been associated in regulatory documents with effects like black hairy tongue or, in rare instances, tooth discoloration. This is sometimes observed in certain pediatric formulations.

Q: What should be done if diarrhea occurs while taking this medicine?

A: If diarrhea occurs, maintaining adequate fluid intake is typically advised to support hydration. Severe, watery, or bloody diarrhea are noted in safety information as potential signs of a serious reaction that should be communicated to a healthcare provider.

Q: Can Novaclox-LB be taken while drinking alcohol?

A: While a direct contraindication is not always present, official cautions advise that alcohol consumption may potentially increase or worsen certain side effects, such as gastrointestinal upset. Use with caution is recommended.

Q: Can this medicine affect a person's ability to drive or operate machinery?

A: Official documents advise that this medicine may cause side effects like dizziness or sleepiness in some individuals. If these effects occur, official information advises that activities requiring full mental alertness, such as driving or operating heavy machinery, should be avoided.

Q: Is it normal to feel tired or fatigued while taking this antibiotic?

A: Official regulatory summaries mention that general side effects, including weakness and discomfort, are occasionally reported with the use of this medication. Any persistent or severe fatigue is generally recommended to be relayed to a healthcare professional.

Q: Is Novaclox-LB typically taken with food or on an empty stomach?

A: The official administration guidelines state that Novaclox-LB may be taken with or without food. However, it is important to take it at a fixed time each day to maintain consistent blood levels. Taking it with food may help minimize stomach discomfort.

Q: Why is it sometimes suggested to take Novaclox-LB around-the-clock?

A: It is suggested to take the medicine at fixed times throughout the day to ensure the concentration of the antibiotic components in the bloodstream remains consistent. This steady level is crucial for the effective, bactericidal action needed to fully eliminate the target bacteria.

Q: Is Novaclox-LB the same as Novaclox?

A: No, they are not the same. Novaclox typically refers to the product containing only the two antibiotics (Amoxicillin and Dicloxacillin). Novaclox-LB is the combination product that includes the added Lactobacillus probiotic component for gut support.

Q: Does Novaclox-LB have any potential for misuse or habit-forming effects?

A: Official safety summaries for this medication indicate that no habit-forming tendencies or potential for misuse have been found or reported with its prescribed use.

Q: Is it common for people to experience joint pain or fever while on this antibiotic?

A: While fever and joint pain are not typically listed as common side effects, they are sometimes documented as symptoms that should be communicated to a healthcare provider for evaluation.

Q: What happens if a patient misses a scheduled dose of Novaclox-LB?

A: The official procedure for a missed dose is to take it as soon as it is remembered. If it is close to the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule continued. The rule emphasizes that a double dose should not be taken to compensate for a missed dose.

Q: Are there different strengths or formulations of Novaclox-LB available?

A: Yes, regulatory documents note that the medicine is available in different forms for oral use. These typically include a capsule for adults and an oral dry syrup or suspension that can be reconstituted for patients who require a liquid format.

Advertisements

How should Novaclox-LB be stored and disposed of?

How to Store and Dispose of Novaclox-LB?

This section outlines the official, label-based requirements for the storage and disposal of Novaclox-LB, as defined by government regulatory authorities.


Official Storage Requirements

Storage Component Regulatory Mandate
Temperature & Environment Store in a cool and dry place, below 30 C (86 F).
Protection Must be protected from direct sunlight, excess heat, and moisture to maintain product stability.
Container Rule Keep the medicine in the original container, tightly closed.
Child Safety Keep out of the sight and reach of children and pets at all times.

Official Disposal Instructions

Disposal Component Regulatory Mandate
Discarding Unused Product Do not dispose of unused or expired product in the household trash or via wastewater (i.e., do not flush).
Approved Method Discard the product through a medication take-back program or a government-approved pharmaceutical waste method.

These instructions define the mandatory environmental and security measures required to maintain the stability of the antibiotic and probiotic components and ensure safe, compliant disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Novaclox-LB found in:

A-Z Index: